This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Fondazione Telethon, Ospedale San Raffaele S.r.l., Yale University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 40 
1 out of 55 
1 out of 1,368 
Years Active: 2019
Title: Nicola Gagliani: Innovator in Immune Response Therapies
Introduction
Nicola Gagliani is a prominent inventor based in New Haven, CT (US). He has made significant contributions to the field of immunology, particularly in the development of therapies aimed at diminishing immune responses. His innovative work has the potential to impact the treatment of various diseases and disorders.
Latest Patents
Gagliani holds a patent for "Compositions and methods for diminishing an immune response." This invention is based on the discovery that T regulatory type 1 (Tr1) cells express specific cell surface markers. These markers facilitate the selection, enrichment, isolation, purification, and administration of Tr1 cells. The ability to utilize these markers enhances Tr1 therapies, offering improved treatment options for a wide range of medical conditions.
Career Highlights
Throughout his career, Gagliani has worked with esteemed institutions such as Yale University and Ospedale San Raffaele S.r.l. His research has focused on advancing the understanding of immune responses and developing innovative therapeutic strategies.
Collaborations
Gagliani has collaborated with notable colleagues, including Richard A. Flavell and Silvia Adriana Gregori. These partnerships have contributed to the advancement of his research and the development of effective therapies.
Conclusion
Nicola Gagliani's work in immunology exemplifies the impact of innovative thinking in medicine. His patent and collaborations highlight his commitment to improving health outcomes through advanced therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile